We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Temodar and Sutent as Therapy for Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00304200
Recruitment Status : Terminated (Funding was inadequate to continue; Companies requested closure.)
First Posted : March 17, 2006
Last Update Posted : February 5, 2009
Sponsor:
Collaborators:
Pfizer
Schering-Plough
Information provided by:
Northern California Melanoma Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : October 2007
  Study Completion Date : January 2009